.STUDY HIGHLIGHT.06 August 2024.
A sizable randomized regulated trial along with cisgender ladies highlights the problems of fidelity to an everyday oral preexposure prevention program as well as shows that twice-yearly shot of lenacapavir may maintain successful HIV prevention degrees over 6 months.